Atlas Molecular Pharma

Derio, Spain

Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients.

Feb 2022

Venture - Series Unknown

Biotechnology Life Science Pharmaceutical Therapeutics

Top Investors

InvereadyKereon PartnersCDTIEzten Venture Capital Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Atlas Molecular Pharma

Who are Atlas Molecular Pharma's investors?

Atlas Molecular Pharma's investors include Inveready, Kereon Partners, CDTI, Ezten Venture Capital Fund.

Where is Atlas Molecular Pharma headquartered?

Atlas Molecular Pharma is headquartered in Derio, Spain.

What does Atlas Molecular Pharma do?

Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients.

What stage is Atlas Molecular Pharma at?

Atlas Molecular Pharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 1, 2022.

MLA

"Atlas Molecular Pharma — Funding & Investors." VCBacked, February 1, 2022, https://www.vcbacked.co/company/atlas-molecular-pharma. Accessed July 1, 2026.

APA

VCBacked. (2022). Atlas Molecular Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/atlas-molecular-pharma

Wikipedia (cite web)

{{cite web |title=Atlas Molecular Pharma — Funding & Investors |url=https://www.vcbacked.co/company/atlas-molecular-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 1, 2022.